Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Cisplatin combined with capecitabine-induced chemotherapy for local nasopharyngeal carcinoma can improve the quality of life and reduce toxic and side effects

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Publication Information:
      BMC, 2021.
    • Publication Date:
      2021
    • Collection:
      LCC:Surgery
      LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
    • Abstract:
      Abstract Background This study was designed to probe into the effect of cisplatin combined with capecitabine on nasopharyngeal carcinoma (NPC). Methods A total of 136 NPC patients treated for the first time in our hospital from January 2016 to March 2017 were collected and divided into two groups: A and B. Among them, 66 in group A were treated with cisplatin intravenous drip, while 70 in group B were treated with capecitabine on the basis of group A. The efficacy, toxic and side effects, and quality of life of the two groups were observed. Results The short-term efficacy of group B was better than that of group A (p
    • File Description:
      electronic resource
    • ISSN:
      1477-7819
    • Relation:
      https://doaj.org/toc/1477-7819
    • Accession Number:
      10.1186/s12957-021-02393-1
    • Accession Number:
      edsdoj.8cc2dd76671e4470b3509b616e20eeee